Difference between revisions of "Team:Freiburg/Lab"
| Line 15: | Line 15: | ||
We want to use the endospores of <i>Bacillus subtilis</i> as a carrier vessel for a prodrug activating enzyme and a nanobody to improve the targeted drug delivery system. | We want to use the endospores of <i>Bacillus subtilis</i> as a carrier vessel for a prodrug activating enzyme and a nanobody to improve the targeted drug delivery system. | ||
| − | <center><img | + | <center><img style="width:350px" src="https://static.igem.org/mediawiki/2016/9/96/T--Freiburg--LaboreSued.jpg" > </center> |
<br><br> | <br><br> | ||
<i>Bacillus subtilis</i> builds these spores under distressed conditions (such as nutrition deficiency). The spores are highly resistant to heat, UV-light and are easy to handle. | <i>Bacillus subtilis</i> builds these spores under distressed conditions (such as nutrition deficiency). The spores are highly resistant to heat, UV-light and are easy to handle. | ||
Revision as of 18:00, 16 October 2016
Lab Summary
We want to use the endospores of Bacillus subtilis as a carrier vessel for a prodrug activating enzyme and a nanobody to improve the targeted drug delivery system.
Bacillus subtilis builds these spores under distressed conditions (such as nutrition deficiency). The spores are highly resistant to heat, UV-light and are easy to handle.
We modified the spores in their coat proteins so that they are expressing the fusion proteins, the Glutathione S-Transferase (GST) and nanobody, on their surface. We experimented with modifications on the genes CotZ, CgeA,CotG and CotB, to see where we could achieve the optimal conditions.
